TLX.AX Telix Pharmaceuticals Limited
Company Analysis
Latest News
🔴 Telix Pharmaceuticals is trading 6% down today after a mixed quarterly update
Telix Pharmaceuticals is trading 5.92% down now at A$13.66 after extending its decline following the October 21 quarterly update. - Third-quarter revenue was...
Telix's 8% Plunge on a 1% Revenue Dip: Are Investors Overreacting or Sending a Warning?
Shares of Telix Pharmaceuticals tumbled 7.9% to A$14.52 on October 21 after the Australian radiopharmaceutical company reported a quarter that looked strong on...
🔴 Telix Pharmaceuticals is trading 7.9% down today after quarterly revenue fell 1% from Q2
Telix Pharmaceuticals is trading at A$14.52, down 7.87%, after quarterly revenue slipped 1% from Q2 despite rising 19% year over year. - The October 21...
🔴 Telix Pharmaceuticals is trading 7.17% down; no clear catalyst identified
Telix Pharmaceuticals is trading at A$14.63, down 7.17%, with no clear catalyst verified. - Q3 revenue was US$245 million, up 19% year over year; Telix...
🔴 Telix Pharmaceuticals is trading 4.64% down with no confirmed catalyst
Telix Pharmaceuticals is trading at A$15.00 (-4.64%), with no verified new company announcement or clear catalyst identified for the October 19, 2026 move. -...
🟢 Telix Pharmaceuticals is trading 4.31% up amid broader biotech-sector gains
Telix Pharmaceuticals is trading at A$15.73, up 4.31%, with broader biotech-sector gains the likeliest explanation, though no direct company-specific catalyst...
🟢 Telix Pharmaceuticals is trading 4% up today amid biotech-sector gains; no direct catalyst confirmed
Telix Pharmaceuticals is trading at A$15.69, up 4.01%, with broader biotech strength the likeliest explanation; no clear company-specific announcement explains...
🔴 Telix Pharmaceuticals is trading 4.05% down
Telix Pharmaceuticals is trading at A$15.64, down 4.05%, with no confirmed catalyst identified. - No company announcement or reliable report directly explains...
🟢 Telix Pharmaceuticals is trading 4.22% up; Pixclara link to move unconfirmed
Telix Pharmaceuticals is trading 4.22% up at A$16.06, though available coverage does not explicitly link the move to the Pixclara announcement. - On October...
🔴 Telix Pharmaceuticals is trading 4.04% down with no confirmed explanation
Telix Pharmaceuticals is trading 4.04% lower at A$14.98 on October 2, 2026; no company announcement clearly explains the decline. - The provided price context...
🔴 Telix Pharmaceuticals is trading 4.3% down today as ITM deal dilution concerns persist
Telix Pharmaceuticals is trading 4.23% down at A$16.08 as investors continue reassessing dilution from its proposed ITM acquisition. - The US$1.65 billion...
🔴 Telix Pharmaceuticals is trading 4.35% down today amid dilution concerns over ITM acquisition
Telix Pharmaceuticals is trading 4.35% down at A$16.06 as investors reassess dilution from its proposed US$1.65 billion acquisition of ITM Isotope Technologies...
🟢 Telix Pharmaceuticals is trading 6.54% up today after announcing its proposed US$1.65 billion ITM deal
Telix Pharmaceuticals is trading 6.54% higher at A$16.79 after announcing its proposed US$1.65 billion acquisition of Germany’s ITM Isotope Technologies...
🟢 Telix Pharmaceuticals is trading 5.01% up today following proposed US$1.65 billion ITM acquisition
Telix Pharmaceuticals is trading at A$16.55, +5.01%, following its proposed acquisition of Germany’s ITM Isotope Technologies Munich for US$1.65 billion...
🔴 Telix Pharmaceuticals is trading 11.71% down today after announcing US$1.65 billion ITM acquisition
Telix Pharmaceuticals is trading 11.71% down at A$15.76 after announcing a proposed acquisition of Germany’s ITM Isotope Technologies Munich. - Reuters...
Telix Bets US$2.35 Billion on Radioactive Cancer Drugs — Can It Digest This Deal Without Choking?
Shares of Telix Pharmaceuticals plunged 10.1% to A$16.05 on Monday after the Melbourne-based radiopharmaceutical company unveiled its largest-ever acquisition:...
🔴 Telix Pharmaceuticals is trading 10.08% down today after announcing a US$1.65 billion ITM acquisition
Telix Pharmaceuticals is trading 10.08% down at A$16.05 after announcing a US$1.65 billion acquisition of ITM Isotope Technologies. - September 21, 2026...
🔴 Telix Pharmaceuticals is trading 4.26% down today with no specific catalyst identified
Telix Pharmaceuticals is trading at A$17.09, -4.26%, with no specific catalyst identified. - No new company-specific announcement dated September 21, 2026 was...
🟢 Telix Pharmaceuticals is trading 4.45% up today after FDA approval of Pixclara
Telix Pharmaceuticals is trading at A$17.62, up +4.45%, after investors continued repricing the company following the September 14 FDA approval of Pixclara,...
🔴 Telix Pharmaceuticals is trading 5% down today after post-approval profit-taking
Telix Pharmaceuticals is trading at A$16.87 (-4.96%) after investors took profits following Pixclara’s FDA approval. - The decline follows the prior session’s...